MMJ Phytotech is a pioneer in the development of
MEDICAL CANNABIS DELIVERY SYSTEMS for international
markets that have regulated medical cannabis laws

 

Cannabidiol capsules Phase 1 clinical trial published

Cannabidiol capsules Phase 1 clinical trial published

Results from the Phase 1 Clinical Trial have been published.  The article “Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology” has been published in an international, peer-reviewed medical journal, Clinical Pharmacology in Drug Development. This clinical trial was completed in March 2016, and demonstrated the safety and high performance of the oral capsule technology, including the effective delivery profile of cannabidiol (“CBD”) compound to trial subjects.  The Phase 1 Clinical Trial also highlighted the favourable bioavailability of the capsules in comparison to Sativex – a market-leading, commercially available cannabinoid oral spray produced by GW Pharmaceuticals (LON: GWP) (NASDAQ: GWPH).